[1]
Н. О. Негрич, “EVALUATION OF RISK IN PATIENTS WITH FAMILY HISTORY OF MULTIPLE SCLEROSIS USING THE NEW BIOMARKER”, pulse, no. 7(43), pp. 51–55, Jun. 2019.